Molecular Partners lists shares on SIX Swiss Exchange
In the form of Molecular Partners, a further biotech company has taken the decision to take advantage of the benefits of raising capital on SIX Swiss Exchange.
The shares of Molecular Partners (MOLN) were today traded for the first time on SIX Swiss Exchange in accordance with the "Main Standard". The opening price was CHF 25.00. Based on this price, this equates to an overall market capitalization of CHF 482 million. The Molecular Partners stock will be included in the SPI® as well as the SXI Life Sciences® and SXI Bio+Medtech® indices.
Leading exchange for life sciences companies
"In the shape of Molecular Partners, we are delighted to welcome a company from the biotech sector toSIX Swiss Exchange. With around 42% of European life sciences market capitalization, we are the continent's leading exchange in this sector," explains Marco Estermann, Head Issuer Relations at SIX Swiss Exchange. "Life sciences companies listed with us thus benefit from a dynamic market environment and enjoy an exceptional level of visibility via-à-vis specialist investors and the media."
IPO: basis for solid future growth
Christian Zahnd, CEO of Molecular Partners, comments: "Together with my founding partners, we started the business ten years ago. Since then we have successfully developed Molecular Partners as a pioneer in the development of multi-benefit therapies with the vision to transform the lives of patients. Our work focuses on significantly improving the lives of patients in need and to create long-term value to our shareholders. I am enthusiastic about the prospects of continuing to build a sustainable biopharmaceutical company and the future growth which will be supported by the IPO."
Numerous benefits for equity issuers
A listing on SIX Swiss Exchange provides companies with access to strongly capitalized Swiss and international investors. In addition, we make things as simple as possible for them with first-class, needs-oriented services, allowing them to efficiently generate capital and sustainable growth. Our appeal extends far beyond the borders of Switzerland. As a result, we have been distinguished as "Exchange of the Year" at the Global Investor/isf Investment Excellence Awards 2014.
A comprehensive overview and helpful information on all topics relevant to going public on SIX Swiss Exchange can be found in the Going Public Guide. Further information on our range of services for issuers can be found on our website.